UPDATE: Credit Suisse Upgrades Thoratec Corporation to Outperform, Raises PT on Higher Near-Term Cost Assumptions

In a report published Tuesday, Credit Suisse analyst Bruce Nudell upgraded the rating on Thoratec Corporation THOR from Neutral to Outperform, and raised the price target from $27.00 to $35.00. In the report, Credit Suisse noted, “We're maintaining our 2014 THOR estimates but lowering our 2015 THOR EPS estimate to $1.12 from $1.29 on higher COGS, opex & tax rate assumptions (2015 sales estimates largely unchanged) given our view that THOR is likely to spend aggressively to fund R&D & commercial endeavors over the next 12 months despite flat expected sales in 2015. Despite our lowered 2015 EPS estimates, we're leaving our out year sales & cost assumptions mostly unchanged and raising our DCF-based price target to $35 from $27 on a higher assumed terminal growth rate.” Thoratec Corporation closed on Monday at $29.20.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorUpgradesAnalyst RatingsBruce NudellCredit Suisse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!